TENX: Chardan Initiates Buy
Chardan Capital initiates coverage on Tenax Therapeutics with a buy rating and a price target of $27
Chardan Capital Initiates Coverage On Tenax Therapeutics with Buy Rating, Announces Price Target of $27
Chardan Capital initiates coverage on Tenax Therapeutics with a buy rating and a price target of $27
Chardan Capital Initiates Coverage On Tenax Therapeutics with Buy Rating, Announces Price Target of $27